Lisa Schwartz and Steven Woloshin, Dartmouth Institute for Health Policy & Clinical Practice (IMAGE)
Caption
In a recently published article in JAMA IM, 'A Clear-Eyed View of Restasis and Chronic Dry Eye Disease,' Lisa Schwartz and Steven Woloshin, physician-researchers at The Dartmouth Institute for Health Policy and Clinical Practice, discuss why US consumers may have paid billions for a drug deemed ineffective in other countries.
Credit
Dartmouth Institute
Usage Restrictions
None
License
Licensed content